701 Pennsylvania Ave. N.W.
Suite 700
Washington, DC 20004
(202) 737-5980
dmaa@dmaa.org
www.dmaa.org

Monday, Nov. 24, 8:30 - 9 a.m.
PACESETTERS SERIES

For almost two decades, clinicians have attempted to monitor patients with chronic conditions, such as congestive heart failure, in their home environment. Many landmark studies have attempted to quantify the benefit of critical outcomes, such as mortality, hospitalization and cost effectiveness. Although each trial was scientifically based, results of their primary outcomes varied widely from study to study. Hear about a meta-analysis of key trials in remote patient management with interim results from trials currently in progress. Variability in results from these trials can be attributed to differences in home monitoring technologies, variation in disease management programs and lack of adequate power in study sample sizes, duration and other metrics. Understand value models and return on investment calculations.

Mark A. Johnson, BSEE, MBA, manager, clinical trials, Digital Health, Intel Corp.

Mark A. Johnson, BSEE, MBA, is clinical trials manager for Intel Corporation's Digital Health division. He is a 20-year veteran of the medical device industry in engineering, business development, clinical studies and marketing. Previously, he was a business development manager for the first implantable RPM technology introduced by Biotronik.

Download Presentation Slides >>

One medical center is using a diabetes management solution that runs on mobile phones to reduce the HbA1c levels of diabetes patients. The program began a rolling 12-month pilot in 2007 targeted at 59 diabetes patients with blood glucose levels greater than 9 percent. Patients starting with HbA1c between eight and nine reduced HbA1c by 0.91 points, while patients with HbA1c more than nine reduced HbA1c by 2.22 points. Learn how patients with diabetes can benefit from an integrated approach of case management and wireless technology to decrease their risk factors and better manage their condition. Discover the role of software applications that run on mobile phones to increase the effectiveness and efficiency of disease management.

Peter Boland, PhD, director, business development, BeWell Mobile Technology

Peter Boland, PhD, is director of business development for BeWell Mobile Technology. As a management consultant on strategy, product development and technology innovation, he works with many leading stakeholders in health care. He has a doctorate from UCLA and a post-graduate certificate from Harvard's Executive Program in health policy and management.

Download Presentation Slides >>

Self-management interventions should teach patients skills needed to effectively take personal control in the face of chronic illness. Hear about outcomes data on 6,514 health plan members who participated in a tailored, online chronic illness self-management program. Self-reported improvements were found in perceived health, quality of life, self-confidence, self-management skills, provider relationships and medication adherence, with decreased stress, worry and productivity impairment. A medical claims analysis shows that 2007 health care costs were $937 less per participant than projected. Understand the key components of an effective self-management program and 90 day outcomes on critical components of effective chronic illness self-management.

Wendy Vida, RD, clinical preventionist, Highmark Blue Cross Blue Shield
Kevin J. Wildenhaus, PhD, director, behavioral science & data analytics, HealthMedia Inc.

Wendy Vida, RD, is the clinical preventionist with Highmark Blue Cross Blue Shield. She has traveled across the country teaching key concepts of nationally-recognized wellness programs such as KidShape and the Dr. Dean Ornish Program for Reversing Heart Disease. Ms. Vida currently works with Highmark's national customers to implement innovative worksite health promotion programs.

Kevin J. Wildenhaus, PhD, is the director of behavioral science and data analytics at HealthMedia Inc. An expert in health behavior change, he has given many national presentations and workshops. Previously, he was director of behavioral science in the department of family medicine for Henry Ford Health System.

Download Presentation Slides >>

Monday, Nov. 24, 1:45 - 2:45 p.m.
SPECIAL INTEREST SESSION

Chronic disease—and innovative strategies to prevent and manage it—span the globe. In this session, leaders from Germany will present two case studies that advance population-based care through both conventional and cutting-edge techniques. Hear about a German telemedicine program for patients with congestive heart failure that reduced hospital stays by 48 percent, total costs by 39.5 percent (6,993 Euros per patient) and mortality rates by 46 percent. The study revealed effective ways to target telemedicine programs to patients who benefit most from the intervention, combine aspects of patient coaching with telemedicine monitoring and measure outcomes in terms of mortality and costs. The session also will present a prospective longitudinal study for type 2 diabetes mellitus that improved clinical parameters (cholesterol, triglycerides, BMI, blood pressure and HbA1c), and reduced the 10-year myocardial infarction risk by 4.5 percent. Hear how these German programs learned how to improve, measure and translate clinical outcomes into economic benefit.

Michael P. Blasius, director, sales & marketing, ArztPartner almeda AG | Download Presentation Slides >>
Lutz Herbarth, MD, MBA, department head, health coaching, KKH Hannover
Thomas Hudler, manager, managed care, Versicherungskammer Bayern | Download Presentation Slides >>
Ruth Philipp, director, health care management, ArztPartner almeda AG | Download Presentation Slides >>

Michael P. Blasius is the director of sales and marketing for ArztPartner almeda AG in Munich. Previously, he was the head of the medical service center of ArztPartner almeda AG and responsible for the implementation and operations of disease management programs for more than 30 insurance companies.

Lutz Herbarth, MD, MBA, is head of the health coaching department at KKH Hannover, one of Germany's big statutory health insurers. After 10 years of clinical experience he entered the KKH working in different projects e. g. reimbursement of inpatient health care and managed care. In 2007 he built up the department for health coaching.

Thomas Hudler is a manager in the department of managed care with Versicherungskammer Bayern, a German insurance company. A sociologist, he is responsible for disease management programs and specializes in telemedicine and program evaluation.

Ruth Philipp is director of health care management at ArztPartner almeda AG, a full service provider of health care in Germany. An industrial psychologist, she has more than six years experience in development and implementation of disease management and integrated care programs.

The use of health risk assessments (HRAs) continues to grow as a tool to identify patients who are candidates for wellness and disease management programs. Learn about a study, conducted in an employer population, which required completion of a self-reported HRA and biometric screening to receive discounts on health insurance. The biometric scores were more likely to identify patients at higher risk (18 percent vs. 1 percent for self-report) and correlated to greater absenteeism (p < .05), with those in the highest-risk group being 122 percent more likely to miss work. Discover the relationship between biometric risk scores and employee productivity, and new solutions to compensate for limitations of self-reported HRAs, including biometrics and predictive modeling, in identifying patients at highest risk for adverse health and reduced productivity.

Adam Hobgood, MS, director, Center for Health Research, Healthways Inc.

Adam Hobgood, MS, is director of the Center for Health Research for Healthways Inc., where he focuses on outcomes research and predictive modeling. Previously, he served as a statistician in the pharmaceutical industry for Covance. He holds a master's in statistics from the University of Kentucky and a bachelor's in mathematics from Freed-Hardeman University.

Download Presentation Slides >>

The disease management community can play a leading role in the march toward data interoperability, with its long experience coordinating information from many players on behalf of the patient. But the opposite also could be true, as interoperability threatens to disrupt existing disease management business models. Explore drivers and barriers toward data interoperability and specific actions members of the disease management community can take to assume leadership roles in advancing the national health information technology agenda. Understand the role of large, non-health care companies, such as Google, Microsoft, Dossia, Intel and Wal-Mart, in this evolving market space.

R. Steven Adams, PhD, chief executive officer, founder, RMD Networks Inc.
Vincent T. Kuraitis, JD, MBA, principal, Better Health Technologies LLC

R. Steven Adams has been founder and chief executive of four companies, including Webb Interactive Services. RMD Networks provides Collaborative Care Solutions that enhance health care communications and coordination of care among multiple providers and patients with complex health issues. RMD currently has its solution deployed in Colorado, Idaho, Washington, California, North Carolina, Georgia, Pennsylvania and New York; including two statewide initiatives focused on the patient-centered medical home and chronic care models.

Vincent T. Kuraitis, JD, MBA, is the principal of Better Health Technologies LLC and author of e-CareManagement blog. He brings 24 years experience: president, vice president of corporate development, vice president of operations, regional director marketing and consultant. Kuraitis' experience spans more than 100 organizations.

Download Presentation Slides >>